Thank you, Mr. Chair.
Thank you for giving us the opportunity to appear before you today to speak about main estimates for the health portfolio. As you mentioned already, joining me today is my honourable colleague, Ms. Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health. Joining us virtually are Stephen Lucas, deputy minister of Health Canada; Dr. Theresa Tam, chief public health officer of Canada; Dr. Harpreet Kochhar, president of the Public Health Agency of Canada; Sylvie Lapointe, vice-president of the policy and programs branch of the Canadian Food Inspection Agency; and Dr. Michael Strong, president of the Canadian Institutes of Health Research.
Let me begin with a few words about the current COVID‑19 situation.
Across Canada, the pandemic outlook is improving. Infection rates have peaked in many areas of the country, followed by a slow decline in hospitalization rates.
After two years of following individual public health measures, people in Canada know what to do to keep themselves and each other safe.
Now, as jurisdictions across the country are adapting their public health measures and restrictions in alignment with their respective situations, we are collectively moving towards more sustainable management of the virus.
Today, I'm here to talk about resourcing plans for the health portfolio.
As you know, we tabled our supplementary estimates (C) on February 19. These estimates seek parliamentary approval for $7.1 billion in new spending. Keeping Canadians healthy and safe has been the top priority for the health portfolio, and these supplementary estimates identify key actions toward this goal. This includes the procurement of rapid tests and therapeutics, funding to address anti-indigenous racism in health care, funding to support long-term care, and advancing pharmacare in Prince Edward Island, among many other important investments.
I'm happy to answer any questions you may have about these estimates later this afternoon.
I would like to turn my focus and your attention to the main estimates for 2022-23. In total, we are seeking $14.47 billion on behalf of the health portfolio, which includes Health Canada, the Public Health Agency of Canada, the Canadian Food Inspection Agency, the Canadian Institutes of Health Research, and the Patented Medicine Prices Review Board.
I’ll start with an overview of Health Canada’s plans.
The 2022‑2023 main estimates reaffirm Health Canada’s focus on providing services that are important to people in Canada, including support for long-term care, improved access to palliative care and safe access to medical assistance in dying.
To achieve these and other objectives, I am seeking a total of $3.88 billion.
As you know, the COVID‑19 pandemic has exacerbated existing mental health and substance use challenges for people in Canada. My colleague Dr. Carolyn Bennett will provide details on the investments that address these challenges.
The main estimates for the Public Health Agency of Canada for 2022-23 propose a total budget of $8.49 billion. This proposed spending will help ensure that PHAC has the resources in place to continue to deliver on its mandate to protect the health of Canadians during the pandemic, including for the procurement of boosters and therapeutics, and the continuity of PHAC's pandemic response and recovery.
The Canadian Food Inspection Agency protects people in Canada against food safety risks, supports the food supply chain and safeguards the health and safety of people working in food manufacturing and distribution.
The CFIA has a proposed net increase of $52.1 million in its 2022‑2023 main estimates.
This budget includes funding for three items: maintaining a daily inspection presence in federally registered meat processing establishments, maintaining and further strengthening food safety measures, and addressing antimicrobial resistance.
As we learn to live with COVID‑19, the importance of investing in health and medical research becomes more important than ever.
The Canadian Institutes of Health Research proposes to spend $1,242 million on health research in 2022‑2023. These investments will help provide the evidence needed to make better health care decisions, during the pandemic and beyond.
In closing, Mr. Chair, the investments I have outlined today will help the health portfolio deliver on its mandate of maintaining and improving the health of people in our country. Our commitments, as set out in our estimates and departmental plans, are a reflection of our most pressing health priorities. They demonstrate how we are taking action, and are an assurance to Canadians that we'll continue to protect and improve the health system.
Thank you for the opportunity to provide my comments. I would be pleased to take questions from the committee after my colleague Dr. Bennett presents her remarks.